Breathalyser app diagnoses disease
Imagine if diagnosing a disease was as easy as breathing into a phone app. No needles and blood samples, no delayed diagnosis. This may soon be possible thanks to new technology developed in South Korea.
Leveraging a phone app, the researchers use gas concentrations in human breath to diagnose certain diseases.
Working under Professor Il-Doo Kim, the Korea Advanced Institute of Science and Technology (KAIST) research team has developed diagnostic sensors using protein-encapsulated nanocatalysts, which can diagnose certain diseases by analysing biomarker gases in a person’s exhaled breath.
Human breath contains diverse components including water vapour, hydrogen, acetone, toluene, ammonia, hydrogen sulfide and carbon monoxide, some of which are closely related to diseases such as asthma, lung cancer, type 1 diabetes mellitus and halitosis.
The researchers started the process by capturing exhaled breaths in a Tedlar bag and the captured breath gases were subsequently injected into a miniaturised sensor system, similar to an alcohol breathalyser. It was then possible to rapidly analyse exhaled breath with a simple process that detects trace changes in exhaled breath components, contributing to early diagnosis of diseases.
The research team developed a disease diagnosis platform that recognises individual breathing patterns by using a multisensor array system with diverse sensing layers and heterogeneous catalysts, so that the people can easily identify health abnormalities. Using a 16-sensor array system, physical conditions can be continuously monitored by analysing concentration changes of biomarkers in exhaled breath gases.
Professor Kim said, “New types of heterogeneous nanocatalysts were synthesised using protein templates with sizes around 2 nm and functionalised on various metal oxide nanofibre-sensing layers. The established sensing libraries can detect biomarker species with high sensitivity and selectivity.
“The new and innovative breath gas analysis platform will be very helpful for reducing medical expenditures and continuous monitoring of physical conditions.”
Patents related to this technology were licensed to two companies in March and June this year.
The study’s results were published in the Journal of the American Chemical Society.
Why data access holds the key to better care
An AI-enabled healthcare sector is a potentially idyllic place, where healthy habits are...
Closing cybersecurity loopholes — lessons from the US
Gregory Garcia was once the most senior cybersecurity professional in all of the United States.
Concept to clinical care: what's holding back healthtech?
Australia is globally recognised for its exceptional medical research output. So why isn't...
